Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Partial Inhibition of Integrin αvβ6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation

Horan, Gerald S., Wood, Susan, Ona, Victor, Li, Dan Jun, Lukashev, Matvey E., Weinreb, Paul H., Simon, Kenneth J., Hahm, Kyungmin, Allaire, Normand E., Rinaldi, Nicola J., Goyal, Jaya, Feghali-Bostwick, Carol A., Matteson, Eric L., O'Hara, Carl, Lafyatis, Robert, Davis, Gerald S., Huang, Xiaozhu, Sheppard, Dean, Violette, Shelia M. · 2008 · American Journal of Respiratory and Critical Care Medicine

Abstract

Rationale Transforming growth factor (TGF)-beta has a central role in driving many of the pathological processes that characterize pulmonary fibrosis. Inhibition of the integrin alpha(v)beta6, a key activator of TGF-beta in lung, is an attractive therapeutic strategy, as it may be possible to inhibit TGF-beta at sites of alpha(v)beta6 up-regulation without affecting other homeostatic roles of TGF-beta. Objectives To analyze the expression of alpha(v)beta6 in human pulmonary fibrosis, and to functionally test the efficacy of therapeutic inhibition of alpha(v)beta6-mediated TGF-beta activation in murine bleomycin-induced pulmonary fibrosis. Methods Lung biopsies from patients with a diagnosis of systemic sclerosis or idiopathic pulmonary fibrosis were stained for alpha(v)beta6 expression. A range of concentrations of a monoclonal antibody that blocks alpha(v)beta6-mediated TGF-beta activation was evaluated in murine bleomycin-induced lung fibrosis. Measurements and main results Alpha(v)beta6 is overexpressed in human lung fibrosis within pneumocytes lining the alveolar ducts and alveoli. In the bleomycin model, alpha(v)beta6 antibody was effective in blocking pulmonary fibrosis. At high doses, there was increased expression of markers of inflammation and macrophage activation, consistent with the effects of TGF-beta inhibition in the lung. Low doses of antibody attenuated collagen expression without increasing alveolar inflammatory cell populations or macrophage activation mark…

Overview

Integrity signals

Registry

Crossref · 10.1164/rccm.200706-805oc

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 56 references

Research works printed but not linked: 5

  1. 1999, Am J Physiol, 276, L814
  2. 2004, Am J Respir Crit Care Med, 171, 889
  3. 2000, Kidney Int, 58, 2310
  4. 2003, Nature, 422, 130
  5. 2005, FASEB J, 19, 1

Cited by

See all 425

Metadata

Authors
Horan, G. S., Wood, S., Ona, V., Li, D. J., Lukashev, M. E., Weinreb, P. H., Simon, K. J., Hahm, K., Allaire, N. E., Rinaldi, N. J., Goyal, J., Feghali-Bostwick, C. A., Matteson, E. L., O'Hara, C., Lafyatis, R., Davis, G. S., Huang, X., Sheppard, D., & Violette, S. M.
Affiliations
  • Biogen (United States) (US)
  • Departments of Exploratory Biology, Fibrosis, Protein Chemistry, Gene Discovery, Molecular Profiling, and Clinical Sciences and Technology, Biogen Idec, Cambridge, Massachusetts
  • Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania
  • Mayo Clinic (US)
  • Section of Rheumatology, Department of Pathology, Boston University School of Medicine, Boston, Massachusetts
  • Boston University (US)
  • University of Vermont (US)
  • University of California, San Francisco (US)
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2008-01-01
Volume
177
Issue
1
Pages
56-65
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2052917153
Cited by
420
References
56
Citations by year
2026: 10 · 2025: 18 · 2024: 18 · 2023: 20 · 2022: 17 · 2021: 37 · 2020: 25 · 2019: 24 · 2018: 32 · 2017: 27 · 2016: 27 · 2015: 26 · 2014: 27 · 2013: 26 · 2012: 33
FWCI
10.37
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Respiratory and Critical Care Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Heart, Lung, and Blood Institute (R37HL053949)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
  • Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
Keywords
pulmonary fibrosis, TGF-beta activation, monoclonal antibody therapy, bleomycin-induced lung fibrosis, systemic sclerosis, idiopathic pulmonary fibrosis, lung inflammation, macrophage activation, collagen expression
MeSH terms
Animals, Antibodies, Monoclonal, Antigens, Neoplasm, Collagen, Disease Models, Animal, Dose-Response Relationship, Drug, Mice, Inbred BALB C, Pulmonary Alveoli, Pulmonary Fibrosis, Scleroderma, Systemic, Integrins, Transforming Growth Factor beta, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Partial Inhibition of Integrin αvβ6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation. https://app.cochat.ai/papers/10.1164/rccm.200706-805oc
The paper
Horan, G. S., Wood, S., Ona, V., Li, D. J., Lukashev, M. E., Weinreb, P. H., Simon, K. J., Hahm, K., Allaire, N. E., Rinaldi, N. J., Goyal, J., Feghali-Bostwick, C. A., Matteson, E. L., O'Hara, C., Lafyatis, R., Davis, G. S., Huang, X., Sheppard, D., & Violette, S. M. (2008). Partial Inhibition of Integrin αvβ6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.200706-805oc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.